Evidence map›Paper›PMID 37083018›Full record

Trial reportDiabetic medicine : a journal of the British Diabetic Association2023

Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes.

Persis V Commissariat, Linda A DiMeglio, Lauren G Kanapka, Lori M Laffel, Kellee M Miller, Barbara J Anderson, Marisa E Hilliard, Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Persis V CommissariatJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-6964-1223
Linda A DiMeglioIndiana University School of Medicine, Riley Hospital for Children at IU Health, Indianapolis, Indiana, USA.ORCID 0000-0002-8033-6078
Lauren G KanapkaJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0003-4440-5168
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-2202-492X
Kellee M MillerType 1 Diabetes Exchange, Boston, Massachusetts, USA.ORCID 0000-0002-5684-8284
Barbara J AndersonBaylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID 0000-0003-1587-7967
Marisa E HilliardBaylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.ORCID 0000-0002-8813-629X
Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Mentoring Behavioral Scientists for Career Development in Pediatric T1D ResearchK12DK097696 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, BARBARA JANE · 2012 to 2016
$1.8M
NIDDK NIH HHS K12 DK097696NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

aimManaging type 1 diabetes in young children can cause significant stress for parents. Continuous glucose monitoring (CGM) may reduce parental burden. The Strategies to Enhance CGM Use in Early Childhood (SENCE) trial randomized parents of children (ages 2 to <8 years) with type 1 diabetes to CGM with family behavioural intervention (CGM + FBI), CGM alone (Standard-CGM) or blood glucose monitoring for 26 weeks before receiving CGM + FBI (BGM-Crossover). This report assesses changes in psychosocial outcomes for all groups over 52 weeks.

methodsCGM + FBI (n = 45), Standard-CGM (n = 42) and BGM-Crossover (n = 44) participants completed psychosocial assessments at baseline, 26 weeks and 52 weeks. Repeated measures linear regression models evaluated change within and between treatment groups.

resultsThe BGM-Crossover group reported improved diabetes burden (Δ -6.9, 95% CI [-11.3, -2.6], p = 0.003), fear of hypoglycaemia (Δ -6.4, CI [-10.1, -2.6], p = 0.002) and technology satisfaction (Δ 7.3, CI [2.4, 12.2], p = 0.005) from 26 to 52 weeks, similar to published findings in the CGM + FBI group over the first 26 weeks. The Standard-CGM group reported increased technology satisfaction (Δ 7.3, CI [0.6, 14.0], p = 0.027) from baseline to 52 weeks. The CGM + FBI group reported less diabetes burden and fear of hypoglycaemia from baseline to 52 weeks, but changes were not statistically significant. Scores from 26 to 52 weeks did not deteriorate.

conclusionsParents demonstrated psychosocial benefits following FBI that appeared to maintain without additional intervention. CGM-focused education with behavioural support likely helps parents of young children with type 1 diabetes reduce burden and worry in the short- and long-term.

Indexed as

Diabetes Mellitus, Type 1HypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolHumansParentsBlood GlucoseburdenCGMfear of hypoglycaemiarandomized clinical trialtype 1 diabetesyoung children

Identifiers

PMID37083018
PMCPMC10524740

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.